Nirmatrelvir-ritonavir for nonhospitalized patients with COVID-19: Case-based approach to assessment and treatment

Affiliations

¹ Information Support Pharmacist and Academic Detailer for the RxFiles Academic Detailing Program at the University of Saskatchewan in Saskatoon. marlys@rxfiles.ca.
² Associate Director of the RxFiles Academic Detailing Program at the University of Saskatchewan.
³ Academic Detailer for the RxFiles Academic Detailing Program.
⁴ Associate Professor and Division Head (Acting) of Infectious Diseases in the College of Medicine at the University of Saskatchewan.
⁵ Assistant Professor of Infectious Diseases and Internal Medicine in the College of Medicine at the University of Saskatchewan.
⁶ Consulting Editor for the RxFiles Academic Detailing Program.

Marlys LeBras et al. Can Fam Physician. 2023 Aug.

. 2023 Aug;69(8):546-549.

doi: 10.46747/cfp.6908546.

¹ Information Support Pharmacist and Academic Detailer for the RxFiles Academic Detailing Program at the University of Saskatchewan in Saskatoon. marlys@rxfiles.ca.
² Associate Director of the RxFiles Academic Detailing Program at the University of Saskatchewan.
³ Academic Detailer for the RxFiles Academic Detailing Program.
⁴ Associate Professor and Division Head (Acting) of Infectious Diseases in the College of Medicine at the University of Saskatchewan.
⁵ Assistant Professor of Infectious Diseases and Internal Medicine in the College of Medicine at the University of Saskatchewan.
⁶ Consulting Editor for the RxFiles Academic Detailing Program.

No abstract available

References

1. Little N. COVID-19 tracker Canada [website]. Saskatoon, SK: COVID19Tracker.ca; 2021. Available from: https://covid19tracker.ca/index.html. Accessed 2023 May 1.
1. Public Health Agency of Canada . COVID-19 vaccination: vaccination coverage. Ottawa, ON: Government of Canada; 2023. Available from: https://health-infobase.canada.ca/covid-19/vaccination-coverage/. Accessed 2023 May 1.
1. Public Health Agency of Canada . COVID-19 epidemiology update: testing and variants. Ottawa, ON: Government of Canada; 2023. Available from: https://health-infobase.canada.ca/covid-19/testing-variants.html. Accessed 2023 May 16.
1. Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet 2022;399(10332):1303-12. Epub 2022 Mar 16. - PMC - PubMed
1. Arbel R, Wolff Sagy Y, Hoshen M, Battat E, Lavie G, Sergienko R, et al. Nirmatrelvir use and severe COVID-19 outcomes during the omicron surge. N Engl J Med 2022;387(9):790-8. Epub 2022 Aug 24. - PMC - PubMed